LIBERTY PARTNERS GROUP, LLC

Lobbying for ANGIOSAFE (CARDIOVASCULAR COALITION) · Manufacturer of products to treat peripheral artery disease.

Amended

The filer submitted a later report covering this same period, so the amounts here have been replaced. Site totals count only the latest version. See the current filing, posted Jul 20, 2026.

Filing 2nd Quarter - Report

Reporting period

2nd Quarter 2026

Apr 1 - June 30 · Posted Jul 20, 2026

Money reported

None

Registrations and no-activity reports carry no figure.

Client based in

California

Official filing document

Government bodies contacted 4

Centers For Medicare and Medicaid Services (CMS)
Health & Human Services, Dept of (HHS)
HOUSE OF REPRESENTATIVES
SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Lobbying activity 2

Medicare/Medicaid

Physician payment and policy issues related to peripheral arterial disease and other cardiovascular issues.

Health Issues

Physician payment and policy issues related to peripheral arterial disease and other cardiovascular issues.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.